Shape

The Puracath Medical team is focused on reducing infectious complications associated with catheter connections. Our proprietary UV technology aims to improve the quality of life of healthcare providers and patients by redefining and simplifying the disinfection process prior to infusion. While decreasing dependence on user compliance, our novel and easy-to-use technology seeks an effective treatment to keep users healthy and protected from catheter connection complications.

Img
Shape

Our Mission

The Puracath Medical team is focused on reducing infectious complications associated with catheter connections. Our proprietary UV technology aims to improve the quality of life of healthcare providers and patients by redefining and simplifying the disinfection process prior to infusion. While decreasing dependence on user compliance, our novel and easy-to-use technology seeks an effective treatment to keep users healthy and protected from catheter connection complications.

Firefly

The Puracath Medical team is focused on reducing infectious complications associated with catheter connections. Our proprietary UV technology aims to improve the quality of life of healthcare providers

NEWS

How UV Disinfection is Transforming Infection Prevention in Medical Settings

10 Oct, 2024
PuraCath Medical™, a venture-backed startup company focusing on the development of technologies to reduce infections in patients with intravascular catheters, announced today that it has published the result of its research on its ultraviolet (UV) light-based intravascular catheter connection disinfection system in the American Journal of Infection Control (AJIC), a peer-reviewed scientific journal published by Elsevier on behalf of the Association for Professionals in Infection Control and Epidemiology.

Disinfection of needleless connectors for catheters in one second using a hand-held UV device

09 Oct, 2024
Central Line-associated Bloodstream Infections (CLABSIs) are deadly bloodstream infections with high mortality and morbidity rates in patients with vascular catheters. In the United States, around 250,000 occur yearly. Of these, about 80,000 occur in intensive care units.
PuraCath Medical Receives 510(k) Clearance for its Needleless Connector for Vascular Access

PuraCath Medical Receives 510(k) Clearance for its Needleless Connector for Vascular Access

By puracath • 03 Aug, 2021
Device is intended for use primarily by ICU nurses during infusions in patients in a critical care setting. PuraCath Medical™, a venture-backed startup company focusing on the development of technologies to reduce infections in patients with intravascular catheters, announced today that it has received 510(k) clearance for its FireFly™ Needleless Connector from the U.S. Food […]

CONTACT US

Sign up to our newsletter

Share by: